Cargando…
NF-κB signaling and its relevance to the treatment of mantle cell lymphoma
Mantle cell lymphoma is an aggressive subtype of non-Hodgkin B cell lymphoma that is characterized by a poor prognosis determined by Ki67 and Mantle Cell International Prognostic Index scores, but it is becoming increasingly treatable. The majority of patients, especially if young, achieve a progres...
Autores principales: | Balaji, Swathi, Ahmed, Makhdum, Lorence, Elizabeth, Yan, Fangfang, Nomie, Krystle, Wang, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002979/ https://www.ncbi.nlm.nih.gov/pubmed/29907126 http://dx.doi.org/10.1186/s13045-018-0621-5 |
Ejemplares similares
-
The B cell receptor signaling pathway in mantle cell lymphoma
por: Merolle, Maria I., et al.
Publicado: (2018) -
Gene mutations and actionable genetic lesions in mantle cell lymphoma
por: Ahmed, Makhdum, et al.
Publicado: (2016) -
Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017) -
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
por: Ye, Haige, et al.
Publicado: (2018) -
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma
por: Huang, Shengjian, et al.
Publicado: (2018)